» Articles » PMID: 20164145

Developmental Neurotoxicity Study of Dietary Bisphenol A in Sprague-Dawley Rats

Abstract

This study was conducted to determine the potential of bisphenol A (BPA) to induce functional and/or morphological effects to the nervous system of F(1) offspring from dietary exposure during gestation and lactation according to the Organization for Economic Cooperation and Development and U.S. Environmental Protection Agency guidelines for the study of developmental neurotoxicity. BPA was offered to female Sprague-Dawley Crl:CD (SD) rats (24 per dose group) and their litters at dietary concentrations of 0 (control), 0.15, 1.5, 75, 750, and 2250 ppm daily from gestation day 0 through lactation day 21. F(1) offspring were evaluated using the following tests: detailed clinical observations (postnatal days [PNDs] 4, 11, 21, 35, 45, and 60), auditory startle (PNDs 20 and 60), motor activity (PNDs 13, 17, 21, and 61), learning and memory using the Biel water maze (PNDs 22 and 62), and brain and nervous system neuropathology and brain morphometry (PNDs 21 and 72). For F(1) offspring, there were no treatment-related neurobehavioral effects, nor was there evidence of neuropathology or effects on brain morphometry. Based on maternal and offspring body weight reductions, the no-observed-adverse-effect level (NOAEL) for systemic toxicity was 75 ppm (5.85 and 13.1 mg/kg/day during gestation and lactation, respectively), with no treatment-related effects at lower doses or nonmonotonic dose responses observed for any parameter. There was no evidence that BPA is a developmental neurotoxicant in rats, and the NOAEL for developmental neurotoxicity was 2250 ppm, the highest dose tested (164 and 410 mg/kg/day during gestation and lactation, respectively).

Citing Articles

Phenols and GABA receptors: from structure and molecular mechanisms action to neuropsychiatric sequelae.

Menzikov S, Zaichenko D, Moskovtsev A, Morozov S, Kubatiev A Front Pharmacol. 2024; 15:1272534.

PMID: 38303988 PMC: 10831359. DOI: 10.3389/fphar.2024.1272534.


Strategic science translation in emerging science: genetically modified crops and Bisphenol A in two cases of contested animal toxicity studies.

Racovita M, Spok A GM Crops Food. 2022; 13(1):142-155.

PMID: 35942901 PMC: 9367667. DOI: 10.1080/21645698.2022.2103368.


Histone deacetylase 2 inhibitor valproic acid attenuates bisphenol A-induced liver pathology in male mice.

Al-Griw M, Alshibani Z, Alghazeer R, Elhensheri M, Tabagh R, Eskandrani A Sci Rep. 2022; 12(1):10258.

PMID: 35715448 PMC: 9205966. DOI: 10.1038/s41598-022-12937-4.


Does Bisphenol A Confer Risk of Neurodevelopmental Disorders? What We Have Learned from Developmental Neurotoxicity Studies in Animal Models.

Welch C, Mulligan K Int J Mol Sci. 2022; 23(5).

PMID: 35270035 PMC: 8910940. DOI: 10.3390/ijms23052894.


Vitamin D mitigates adult onset diseases in male and female mice induced by early-life exposure to endocrine disruptor BPA.

Al-Griw M, Marwan Z, Hdud I, Shaibi T Open Vet J. 2021; 11(3):407-417.

PMID: 34722204 PMC: 8541727. DOI: 10.5455/OVJ.2021.v11.i3.12.


References
1.
Tyl R, Myers C, Marr M, Castillo N, Seely J, Sloan C . Three-generation evaluation of dietary para-nonylphenol in CD (Sprague-Dawley) rats. Toxicol Sci. 2006; 92(1):295-310. DOI: 10.1093/toxsci/kfj203. View

2.
Moser V, McDaniel K, Phillips P . Rat strain and stock comparisons using a functional observational battery: baseline values and effects of amitraz. Toxicol Appl Pharmacol. 1991; 108(2):267-83. DOI: 10.1016/0041-008x(91)90117-w. View

3.
Holson R, Freshwater L, Maurissen J, Moser V, Phang W . Statistical issues and techniques appropriate for developmental neurotoxicity testing: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints. Neurotoxicol Teratol. 2007; 30(4):326-48. DOI: 10.1016/j.ntt.2007.06.001. View

4.
Irwin S . Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia. 1968; 13(3):222-57. DOI: 10.1007/BF00401402. View

5.
Adams J, Kimmel C, Nelson C, Reiter L, Sobotka T, Tilson H . Collaborative Behavioral Teratology Study: protocol design and testing procedures. Neurobehav Toxicol Teratol. 1985; 7(6):579-86. View